R. Gierke

发表

Coronavirus Disease 2019 in Children — United States, February 12–April 2, 2020

T. Skoff, S. Bialek, T. Pilishvili, 2020, MMWR. Morbidity and mortality weekly report.

Multiple‐Aetiology Enteric Infections Involving Non‐O157 Shiga Toxin‐Producing Escherichia coli – FoodNet, 2001–2010

M. Tobin-D'Angelo, P. Griffin, C. Medus, 2014, Zoonoses and public health.

Incremental Cost-Effectiveness of 13-valent Pneumococcal Conjugate Vaccine for Adults Age 50 Years and Older in the United States

L. Kim, T. Pilishvili, R. Gierke, 2016, Journal of General Internal Medicine.

Prevention of Antibiotic-Nonsusceptible Invasive Pneumococcal Disease With the 13-Valent Pneumococcal Conjugate Vaccine.

W. Schaffner, R. Lynfield, L. Harrison, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pediatric Bacterial Meningitis Surveillance in the World Health Organization African Region Using the Invasive Bacterial Vaccine-Preventable Disease Surveillance Network, 2011–2016

F. Lessa, M. Antonio, A. von Gottberg, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pneumococcal Conjugate Vaccine Breakthrough Infections: 2001–2016

W. Schaffner, C. Whitney, L. Harrison, 2020, Pediatrics.

Penicillin Resistance of Nonvaccine Type Pneumococcus before and after PCV13 Introduction, United States

Cheryl P. Andam, W. Hanage, C. Worby, 2017, Emerging infectious diseases.

Genome-wide association analyses of invasive pneumococcal isolates identify a missense bacterial mutation associated with meningitis

L. McGee, T. Pilishvili, B. Beall, 2019, Nature Communications.

Multistate Outbreak of Respiratory Infections Among Unaccompanied Children, June 2014-July 2014.

Maureen H Diaz, C. Whitney, Seemalata Jain, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pneumococcal Disease

Miwako Kobayashi, R. Gierke, A. Wodi, 2013 .

Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022

K. Poehling, H. Talbot, T. Pilishvili, 2022, MMWR. Morbidity and mortality weekly report.

Impact of 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease Among Adults With HIV—United States, 2008–2018

W. Schaffner, L. Harrison, M. Farley, 2022, Journal of acquired immune deficiency syndromes.

Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

C. Whitney, M. Moore, Miwako Kobayashi, 2015, MMWR. Morbidity and mortality weekly report.

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6–18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

C. Whitney, A. Harris, M. Moore, 2013, MMWR. Morbidity and mortality weekly report.

Upsurge of conjugate vaccine serotype 4 invasive pneumococcal disease clusters among adults experiencing homelessness in California, Colorado, and New Mexico.

L. McGee, E. Mosites, T. Pilishvili, 2020, The Journal of infectious diseases.

Serotype Distribution of Remaining Pneumococcal Meningitis in the Mature PCV10/13 Period: Findings from the PSERENADE Project

S. Zeger, P. De Wals, L. Hammitt, 2021, Microorganisms.

Pneumococcal Serotype 5 Colonization Prevalence Among Newly Arrived Unaccompanied Children 1 Year After an Outbreak—Texas, 2015

C. Whitney, S. Waterman, Curi Kim, 2017, The Pediatric infectious disease journal.

Use of 15-Valent Pneumococcal Conjugate Vaccine Among U.S. Children: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022

W. Schaffner, C. Whitney, K. Poehling, 2022, MMWR. Morbidity and mortality weekly report.

1470. Epidemiology of Invasive Pneumococcal Disease (IPD) Following 18 years of Pneumococcal Conjugate Vaccine (PCV) Use in the United States

W. Schaffner, L. Harrison, M. Farley, 2020 .

Direct and Indirect Impact of 13-valent Pneumococcal Conjugate Vaccine (PCV13) on Invasive Pneumococcal Disease (IPD) Among Children and Adults in the U.S.

W. Schaffner, C. Whitney, R. Lynfield, 2016, Open Forum Infectious Diseases.

Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel

D. Beiser, S. Schrag, D. Anderson, 2021, The New England journal of medicine.

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices

Miwako Kobayashi, T. Pilishvili, A. Leidner, 2019, MMWR. Morbidity and mortality weekly report.

Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 — United States, February 12–March 28, 2020

Emily N. Ussery, T. Skoff, M. Ritchey, 2020, MMWR. Morbidity and mortality weekly report.

Geographic Differences in COVID-19 Cases, Deaths, and Incidence — United States, February 12–April 7, 2020

Tamara Pilishvili, Emily N. Ussery, Benjamin Silk, 2020, MMWR. Morbidity and mortality weekly report.

Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021

James C. Crosby, D. Beiser, S. Schrag, 2021, MMWR. Morbidity and mortality weekly report.

Genome-wide association analyses of invasive pneumococcal isolates identify a missense bacterial mutation associated with meningitis

L. McGee, T. Pilishvili, B. Beall, 2019, Nature Communications.

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

C. Whitney, M. Moore, T. Pilishvili, 2014, MMWR. Morbidity and mortality weekly report.

Simplified Pneumococcal Vaccination Schedules for Adults Age 50 and Over Lead to Worse Health

L. Kim, T. Pilishvili, R. Gierke, 2017 .

Using whole genome sequencing to identify resistance determinants and predict antimicrobial resistance phenotypes for year 2015 invasive pneumococcal disease isolates recovered in the United States.

W. Schaffner, R. Lynfield, S. Khanlian, 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Pneumococcal Vaccine for Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023

K. Poehling, Miwako Kobayashi, T. Pilishvili, 2023, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

C. Whitney, M. Moore, Miwako Kobayashi, 2015, MMWR. Morbidity and mortality weekly report.

Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease among children in the United States between 2010 and 2019: An indirect cohort study

M. Farley, A. Thomas, J. Verani, 2024, Vaccine.